NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough. Barchart · Aug 21
FDA Vaccine Chief Claims COVID Shots Linked to 'At Least 10' Child Deaths but Offers No Data US FDA's vaccine director Dr. Vinay Prasad wrote a memo to their staff that claimed multiple child deaths were related to COVID-19 vaccines without data to back it up. International Business Times UK · Nov 30, 2025
Under the Radar: Why This 600M Fund Manager Keeps Outperforming Wall Street While everyone else is running in circles over the next week breathlessly talking about what Buffett, Ackman, Pabrai and Woods are buying, I will be calmly going through the 13f filings of obscure money managers who know one has heard of, have little to no social media presence Benzinga · Nov 18, 2025
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine. Benzinga · Oct 14, 2025
Novavax Shares Are Trading Higher Thursday: What's Going On? Novavax, Inc. (NASDAQ:NVAX) shares are trading lower Thursday after the company announced it has extended its $225 million convertible notes deal. Additionally, B of A securities downgraded the stock yesterday from a Neutral rating to a Underperform rating and cut its price target from $9 to $7. Benzinga · Aug 21, 2025
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales On Wednesday, Novavax Inc. (NASDAQ:NVAX) reported second-quarter 2025 sales of $239.24 million, compared to $415 million a year ago, beating the consensus of $156.29 million. Benzinga · Aug 6, 2025
Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector Shares of Novavax Inc (NASDAQ:NVAX) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc (NASDAQ:MRNA) reported disappointing second-quarter financial results and cut its full-year forecast. Benzinga · Aug 1, 2025
Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate. Benzinga · Jul 24, 2025
Analysts Think These Stocks Could More Than Double in Value Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well. MarketBeat · May 23, 2025
FDA panel debates COVID vaccine recipe as questions swirl about fall shots Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter The Independent UK · May 22, 2025
RFK Jr. pledged not to upend US vaccine system, but big changes are underway Health agencies working under Robert F The Independent UK · May 19, 2025
FDA approves Novavax COVID-19 shot but with unusual restrictions The Food and Drug Administration has approved Novavax's COVID-19 vaccine but with unusual restrictions The Independent UK · May 18, 2025
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from Novavax The Independent UK · Apr 28, 2025
How ‘revenge of the Covid contrarians’ unleashed by RFK Jr puts broader vaccine advances at risk The health secretary has pledged to fight chronic illness, but experts say he risks increasing it with department cuts The Guardian - US · Apr 26, 2025
The Independent UK · Apr 23, 2025 Novavax says its COVID-19 shot is on track for full FDA approval after delay Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the Food and Drug Administration
Fortune · Mar 31, 2025 Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies' Massive cuts to personnel and funding within the Department of Health and Human Services presents a headache for vaccine approval and development, analysts say.
Barchart · Jan 7, 2025 Options Alert: Why Novavax (NVAX) Could Be the Biotech Hero of Trump 2.0 While vaccine-related investments have broadly suffered following Trump’s electoral victory, NVAX stock may represent a compelling compromise.
The Independent UK · Nov 7, 2024 Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread
LiveScience · Oct 25, 2024 Older adults should get 2 doses of the updated COVID shot, CDC says The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months apart.
The Independent UK · Sep 25, 2024 It's time to roll up sleeves for new COVID, flu shots Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines
Fortune · Sep 18, 2024 Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.
The Conversation · Sep 9, 2024 New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.
Fortune · Aug 29, 2024 New COVID vaccines are here. What to know about 2024–25 shots as summer surge continues Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
The Independent UK · Aug 27, 2024 A new Covid vaccine is available. Here’s why some people might not want it right away Updated Covid vaccines were approved by the FDA earlier this month
Salon · Aug 22, 2024 New COVID vaccines approved early New shots from Pfizer and Moderna will be available within days. Here's how to get yours